AIP
OLMA icon

Ameritas Investment Partners’s Olema Pharmaceuticals OLMA Stock Holding History

Ameritas Investment Partners’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89K Buy
7,115
+1,399
+24% +$18.7K ﹤0.01% 1911
2026
Q1 		$85.2K Buy
5,716
+741
+15% +$16.5K ﹤0.01% 1779
2025
Q4 		$124K Hold
4,975
– – ﹤0.01% 1566
2025
Q3 		$48.7K Sell
4,975
-1,105
-18% -$6.63K ﹤0.01% 2141
2025
Q2 		$25.9K Buy
6,080
+2,168
+55% +$9.67K ﹤0.01% 2545
2025
Q1 		$14.7K Hold
3,912
– – ﹤0.01% 2675
2024
Q4 		$22.8K Hold
3,912
– – ﹤0.01% 2572
2024
Q3 		$46.7K Hold
3,912
– – ﹤0.01% 2231
2024
Q2 		$42.3K Buy
3,912
+1,695
+76% +$18.4K ﹤0.01% 2234
2024
Q1 		$25.1K Hold
2,217
– – ﹤0.01% 2471
2023
Q4 		$31.1K Hold
2,217
– – ﹤0.01% 2389
2023
Q3 		$27.4K Hold
2,217
– – ﹤0.01% 2404
2023
Q2 		$20K Buy
+2,217
New +$13.4K ﹤0.01% 2565
2022
Q2 		– Sell
-1,931
Closed -$8K – 3185
2022
Q1 		$8K Hold
1,931
– – ﹤0.01% 2862
2021
Q4 		$18K Hold
1,931
– – ﹤0.01% 2689
2021
Q3 		$53K Buy
1,931
+944
+96% +$25.5K ﹤0.01% 2114
2021
Q2 		$28K Hold
987
– – ﹤0.01% 2551
2021
Q1 		$33K Buy
+987
New +$42.3K ﹤0.01% 2318

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Ameritas Investment Partners's OLMA Position: Q2 2026 in Review

Ameritas Investment Partners increased its Olema Pharmaceuticals (OLMA) stake by 24% in Q2 2026, buying an estimated $18.7K and bringing the position to 7,115 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.

Ameritas Investment Partners first reported a position in OLMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $124K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Ameritas Investment Partners held 7,115 shares of Olema Pharmaceuticals worth $89K as of Q2 2026.
  • Ameritas Investment Partners bought 1,399 Olema Pharmaceuticals shares in Q2 2026, an estimated $18.7K.
  • Olema Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1911 holding.
  • Ameritas Investment Partners first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Ameritas Investment Partners's Olema Pharmaceuticals position peaked at $124K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.